Cargando…
Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome
BACKGROUND & AIMS: Metabolic syndrome (MetS) is characterized by obesity, glucose intolerance, and hepatic steatosis. Alterations in the gut microbiome play important roles in the development of MetS. However, the mechanisms by which this occurs are poorly understood. Dual oxidase 2 (DUOX2) is a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468370/ https://www.ncbi.nlm.nih.gov/pubmed/37369278 http://dx.doi.org/10.1016/j.jcmgh.2023.06.009 |
_version_ | 1785099225043828736 |
---|---|
author | Hazime, Hajar Ducasa, G. Michelle Santander, Ana M. Brito, Nivis González, Eddy E. Ban, Yuguang Kaunitz, Jonathan Akiba, Yasutada Fernández, Irina Burgueño, Juan F. Abreu, Maria T. |
author_facet | Hazime, Hajar Ducasa, G. Michelle Santander, Ana M. Brito, Nivis González, Eddy E. Ban, Yuguang Kaunitz, Jonathan Akiba, Yasutada Fernández, Irina Burgueño, Juan F. Abreu, Maria T. |
author_sort | Hazime, Hajar |
collection | PubMed |
description | BACKGROUND & AIMS: Metabolic syndrome (MetS) is characterized by obesity, glucose intolerance, and hepatic steatosis. Alterations in the gut microbiome play important roles in the development of MetS. However, the mechanisms by which this occurs are poorly understood. Dual oxidase 2 (DUOX2) is an antimicrobial reduced nicotinamide adenine dinucleotide phosphate oxidase expressed in the gut epithelium. Here, we posit that epithelial DUOX2 activity provides a mechanistic link between the gut microbiome and the development of MetS. METHODS: Mice carrying an intestinal epithelial-specific deletion of dual oxidase maturation factor 1/2 (DA IEC-KO), and wild-type littermates were fed a standard diet and killed at 24 weeks. Metabolic alterations were determined by glucose tolerance, lipid tests, and body and organ weight measurements. DUOX2 activity was determined by Amplex Red. Intestinal permeability was determined by fluorescein isothiocyanate–dextran, microbial translocation assessments, and portal vein lipopolysaccharide measurements. Metagenomic analysis of the stool microbiome was performed. The role of the microbiome was assessed in antibiotic-treated mice. RESULTS: DA IEC-KO males showed increased body and organ weights accompanied by glucose intolerance and increased plasma lipid and liver enzyme levels, and increased adiposity in the liver and adipose tissue. Expression of F4/80, CD68, uncoupling protein 1, carbohydrate response element binding protein, leptin, and adiponectin was altered in the liver and adipose tissue of DA IEC-KO males. DA IEC-KO males produced less epithelial H(2)O(2), had altered relative abundance of Akkermansiaceae and Lachnospiraceae in stool, and showed increased portal vein lipopolysaccharides and intestinal permeability. Females were protected from barrier defects and MetS, despite producing less H(2)O(2). Antibiotic depletion abrogated all MetS phenotypes observed. CONCLUSIONS: Intestinal epithelial inactivity of DUOX2 promotes MetS in a microbiome-dependent manner. |
format | Online Article Text |
id | pubmed-10468370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104683702023-09-01 Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome Hazime, Hajar Ducasa, G. Michelle Santander, Ana M. Brito, Nivis González, Eddy E. Ban, Yuguang Kaunitz, Jonathan Akiba, Yasutada Fernández, Irina Burgueño, Juan F. Abreu, Maria T. Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: Metabolic syndrome (MetS) is characterized by obesity, glucose intolerance, and hepatic steatosis. Alterations in the gut microbiome play important roles in the development of MetS. However, the mechanisms by which this occurs are poorly understood. Dual oxidase 2 (DUOX2) is an antimicrobial reduced nicotinamide adenine dinucleotide phosphate oxidase expressed in the gut epithelium. Here, we posit that epithelial DUOX2 activity provides a mechanistic link between the gut microbiome and the development of MetS. METHODS: Mice carrying an intestinal epithelial-specific deletion of dual oxidase maturation factor 1/2 (DA IEC-KO), and wild-type littermates were fed a standard diet and killed at 24 weeks. Metabolic alterations were determined by glucose tolerance, lipid tests, and body and organ weight measurements. DUOX2 activity was determined by Amplex Red. Intestinal permeability was determined by fluorescein isothiocyanate–dextran, microbial translocation assessments, and portal vein lipopolysaccharide measurements. Metagenomic analysis of the stool microbiome was performed. The role of the microbiome was assessed in antibiotic-treated mice. RESULTS: DA IEC-KO males showed increased body and organ weights accompanied by glucose intolerance and increased plasma lipid and liver enzyme levels, and increased adiposity in the liver and adipose tissue. Expression of F4/80, CD68, uncoupling protein 1, carbohydrate response element binding protein, leptin, and adiponectin was altered in the liver and adipose tissue of DA IEC-KO males. DA IEC-KO males produced less epithelial H(2)O(2), had altered relative abundance of Akkermansiaceae and Lachnospiraceae in stool, and showed increased portal vein lipopolysaccharides and intestinal permeability. Females were protected from barrier defects and MetS, despite producing less H(2)O(2). Antibiotic depletion abrogated all MetS phenotypes observed. CONCLUSIONS: Intestinal epithelial inactivity of DUOX2 promotes MetS in a microbiome-dependent manner. Elsevier 2023-06-25 /pmc/articles/PMC10468370/ /pubmed/37369278 http://dx.doi.org/10.1016/j.jcmgh.2023.06.009 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Hazime, Hajar Ducasa, G. Michelle Santander, Ana M. Brito, Nivis González, Eddy E. Ban, Yuguang Kaunitz, Jonathan Akiba, Yasutada Fernández, Irina Burgueño, Juan F. Abreu, Maria T. Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome |
title | Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome |
title_full | Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome |
title_fullStr | Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome |
title_full_unstemmed | Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome |
title_short | Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome |
title_sort | intestinal epithelial inactivity of dual oxidase 2 results in microbiome-mediated metabolic syndrome |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468370/ https://www.ncbi.nlm.nih.gov/pubmed/37369278 http://dx.doi.org/10.1016/j.jcmgh.2023.06.009 |
work_keys_str_mv | AT hazimehajar intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT ducasagmichelle intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT santanderanam intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT britonivis intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT gonzalezeddye intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT banyuguang intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT kaunitzjonathan intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT akibayasutada intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT fernandezirina intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT burguenojuanf intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome AT abreumariat intestinalepithelialinactivityofdualoxidase2resultsinmicrobiomemediatedmetabolicsyndrome |